Journal of Biotechnology 184 (2014) 128–137
Contents lists available at ScienceDirect
Journal of Biotechnology
j ourna l ho me pa ge: www.elsevier.com/locate/jbiotec
Methylation and subsequent glycosylation of 7,8-dihydroxyflavone
Niranjan Koirala
1
, Ramesh Prasad Pandey
1
, Prakash Parajuli,
Hye Jin Jung, Jae Kyung Sohng
∗
Department of Pharmaceutical Engineering, Institute of Biomolecule Reconstruction, Sun Moon University, Asansi, Chungnam 336-708, Republic of Korea
a r t i c l e i n f o
Article history:
Received 10 March 2014
Received in revised form 12 May 2014
Accepted 13 May 2014
Available online 22 May 2014
Keywords:
Methylation
Glycosylation
7,8-Dihydroxyflavone
Streptomyces peucetius
Cytoprotective
a b s t r a c t
An O-methyltransferase SpOMT2884, originating from Streptomyces peucetius ATCC 27952, was cloned,
expressed, and applied for the production of target metabolite from Escherichia coli. Biochemical charac-
terization of the 25 kDa recombinant protein by in vitro and in vivo experiments showed that SpOMT2884
was an S-adenosyl-l-methionine-dependent O-methyltransferase. SpOMT2884 catalyzed O-methylation
of different classes of flavonoids such as flavones (7,8-dihydroxyflavone (7,8-DHF), luteolin), flavonols
(quercetin, rutin), flavanone (naringenin), and isoflavonoids (daidzein, formononetin). Biotransforma-
tion of 7,8-DHF, a preferred substrate of SpOMT2884, in a grown-induced culture of E. coli BL21 (DE3)
harboring the recombinant pET-28a-SpOMT2884 stoichiometrically converted 7,8-DHF into 7-hydroxy-
8-methoxyflavone, which was confirmed by liquid chromatography, mass spectrometry and various
nuclear magnetic resonance (NMR) spectroscopy analyses. In order to improve the biotransformation
substrate, time and media parameters were optimized and the production was scaled up using a 3-L
fermentor. The maximum yield of 7-hydroxy-8-methoxyflavone was 192 M (52.57 mg/L), representing
almost 96% bioconversion within 12 h, when 200 M of 7,8-DHF was supplemented in the culture. Fur-
ther, the 7-hydroxy-8-methoxyflavone was purified in large scale and was used as a substrate separately
for in vitro glycosylation to produce glucose, galactose and 2-deoxyglucose conjugated at 7th hydroxyl
position of 7-hydroxy-8-methoxyflavone. Biological activity showed that 7-hydroxy-8-methoxyflavone
had long term cytoprotective and antioxidant effects compared to 7,8-DHF suggesting that methylation
enhances the stability of substrate and glycosylation has proved to increase the water solubility.
© 2014 Elsevier B.V. All rights reserved.
1. Introduction
Flavones are widely distributed in celery and parsley, among a
number of other vegetables and herbs (Hertog et al., 1993; Peterson
and Dwyer, 1998). Since, they are present in many daily consumed
foods, vegetables, beverages, and fruits; they are the active ingre-
dients of human diet. But, the pharmacological application of these
compounds is limited because of the low water solubility and
instability. Moreover, the free hydroxyl groups are susceptible to
glucoronidation, sulfation and oxidation reactions in the intestine
and liver that avoids them to pass intact into the systemic circula-
tion (Otake et al., 2002). Methylation of the free hydroxyl groups
in the flavones dramatically increases their metabolic stability and
enhances the membrane transport, leading to facilitated absorp-
tion and greatly increased oral bioavailability (Walle, 2009). Some
of the methylated flavones show remarkable inhibitory effects on
∗
Corresponding author. Tel.: +82 41 530 2246; fax: +82 41 544 2919.
E-mail address: sohng@sunmoon.ac.kr (J.K. Sohng).
1
These authors are equally contributed to this work.
carcinogen activating enzymes (Wen and Walle, 2006), effects on
multidrug resistance proteins (MRPs), and fungicidal properties
(Bernini et al., 2011).
7,8-Dihydroxyflavone (7,8-DHF) is a flavonoid that is abun-
dantly present in fruits and vegetables (Harborne and Williams,
2002). It can cross the blood–brain barrier (Andero et al., 2011) has
the potential to act as a mammalian neurotrophin, brain-derived
neurotrophic factor (BDNF) ligand for TrkB (Mantilla and Ermilov,
2012), and is capable of inducing angiogenesis (Williams, 2011).
7,8-DHF has been identified as a potent TrkB agonist (Jang et al.,
2010). It also prevents aging-induced morphological changes, and
plasticity of neurons. In addition, it can raise the cellular glutathione
levels, which ultimately reduces the reactive oxygen species (ROS)
production caused by glutamate, reducing the chances of neurode-
generative diseases induced by ROS (Chen et al., 2011). Findings
from Huai group have suggested that neuro-protective 7,8-DHF has
also a vasorelaxing and antihypertensive properties (Huai et al.,
2014) suggesting its use in treatment of cardiovascular diseases.
S-adenosyl-l-methionine (AdoMet) dependent O-
methyltransferase (OMT) functions in transferring methyl moiety
in the biosynthesis of several natural products (Wils et al., 2013)
http://dx.doi.org/10.1016/j.jbiotec.2014.05.005
0168-1656/© 2014 Elsevier B.V. All rights reserved.